BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10213482)

  • 1. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
    Garcia-Rostan G; Tallini G; Herrero A; D'Aquila TG; Carcangiu ML; Rimm DL
    Cancer Res; 1999 Apr; 59(8):1811-5. PubMed ID: 10213482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-catenin mutations in biliary tract cancers: a population-based study in China.
    Rashid A; Gao YT; Bhakta S; Shen MC; Wang BS; Deng J; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Apr; 61(8):3406-9. PubMed ID: 11309300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries].
    Tanyi J; Páy A; Rigó J; Nagy B; Papp Z
    Orv Hetil; 2000 May; 141(21):1115-9. PubMed ID: 10876313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin mutations in human prostate cancer.
    Voeller HJ; Truica CI; Gelmann EP
    Cancer Res; 1998 Jun; 58(12):2520-3. PubMed ID: 9635571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin mutation in carcinoma of the uterine endometrium.
    Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S
    Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix.
    Shinohara A; Yokoyama Y; Wan X; Takahashi Y; Mori Y; Takami T; Shimokawa K; Tamaya T
    Gynecol Oncol; 2001 Sep; 82(3):450-5. PubMed ID: 11520139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
    Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
    Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
    Kim HS; Hong EK; Park SY; Kim WH; Lee HS
    Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
    Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Catenin alteration in cancer of the ampulla of Vater.
    Kawakami M; Kimura Y; Furuhata T; Zenbutsu H; Yanai Y; Mukaiya M; Satoh Y; Murata S; Hirata K
    J Exp Clin Cancer Res; 2002 Mar; 21(1):23-7. PubMed ID: 12071524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
    Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
    J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors.
    Takahashi M; Fukuda K; Sugimura T; Wakabayashi K
    Cancer Res; 1998 Jan; 58(1):42-6. PubMed ID: 9426055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
    Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.
    Takahashi M; Nakatsugi S; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jun; 21(6):1117-20. PubMed ID: 10836998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
    Koch A; Denkhaus D; Albrecht S; Leuschner I; von Schweinitz D; Pietsch T
    Cancer Res; 1999 Jan; 59(2):269-73. PubMed ID: 9927029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T; Vidal-Puig A
    Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer.
    Park WS; Oh RR; Park JY; Lee SH; Shin MS; Kim YS; Kim SY; Lee HK; Kim PJ; Oh ST; Yoo NJ; Lee JY
    Cancer Res; 1999 Sep; 59(17):4257-60. PubMed ID: 10485468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.